Key result
Higher central augmentation index is marginally linked to increased cerebral small vessel disease.
Why the study?
This study aimed to assess the association between pressure wave reflections, measured by augmentation index, and cerebral small vessel disease identified by neuroimaging, and explore differences by measurement site.
Is a higher augmentation index (AIx) associated with neuroimaging markers of cerebral small vessel disease (cSVD) in adults from general and high cardiovascular risk populations?
Meta-Analysis (n=6,774)
Yes
Is a higher augmentation index (AIx) associated with neuroimaging markers of cerebral small vessel disease (cSVD) in adults from general and high cardiovascular risk populations?
This systematic review and meta-analysis found only a marginal positive association between central augmentation index and neuroimaging markers of cerebral small vessel disease, suggesting limited clinical relevance of global pressure wave reflection indices for brain microcirculation assessment.
Answers are grounded in this paper and cite their sources.
Marginal AIx-cSVD link indicates limited clinical utility; leaves open whether wave reflection informs cerebral microvascular risk beyond standard measures.
BACKGROUND: Augmentation index (Aix) is a widely used index of pressure wave reflections (PWRs) derived from noninvasive blood pressure waves recordings and pulse wave analysis. Cerebral small vessel disease (cSVD) comprises various pathological processes affecting the brain's microvasculature and is a major cause of vascular cognitive impairment, ischemic, and hemorrhagic stroke. This meta-analysis aimed to assess the association between PWRs, as measured by AIx, and cSVD as identified through neuroimaging biomarkers, and to explore potential differences based on arterial site of AIx measurement. METHODS: Following a predefined protocol adhering to the Meta-Analysis of Observational Studies in Epidemiology guidelines, nine studies comprising a total of 6,774 participants were included. Pooled effect estimates were calculated to evaluate the relationship between AIx and cSVD markers, including white matter hyperintensities (WMH). RESULTS: A marginal positive association was observed between AIx and cSVD [central (carotid and aortic) AIx: β=0.04 (95% CI: 0.01-0.07) per SD increase; carotid AIx: β=0.05 (95% CI: 0.00-0.09); aortic AIx: β=0.03 (95% CI: 0.00-0.06)]. Similar results were found for the association between AIx and WMH [central (carotid and aortic) AIx: β=0.05 (95% CI: 0.01-0.08); carotid AIx: β=0.05 (95% CI: 0.00-0.10); aortic AIx: β=0.05 (95% CI: 0.00-0.010)]. CONCLUSIONS: AIx showed a marginal positive association with cSVD, but the clinical relevance remains unclear. Substantial heterogeneity across studies, along with the absence of data on other PWR indices, limits the robustness and generalizability of these findings. Future research should employ advanced methodologies capable of assessing local PWR coefficients to better elucidate the relationship between PWRs and brain microcirculation.
No takes yet. Share an insight, caveat, or question.
Karachalias et al. (2025) conducted a meta-analysis in Cerebral small vessel disease (cSVD) (n=6,774). Central (carotid and aortic) Augmentation Index (AIx) as a measure of pressure wave reflections was evaluated on Cerebral small vessel disease (cSVD) neuroimaging markers (lacunes, white matter hyperintensities, cerebral microbleeds) (β 0.04 per SD increase, 95% CI 0.01-0.07). Central augmentation index showed a marginal positive association with cerebral small vessel disease across 9 studies.
Synapse has enriched 10 related papers. Consider them for comparative context: